Monoclonal antibodies are indispensable tools in scientific research, diagnostics, and therapeutic applications, derived from a single unique parent cell for unparalleled specificity. This category encompasses antibodies produced through the fusion of myeloma cells with spleen cells from an immunized host, creating hybridomas that generate antibodies targeting a single epitope. Their high specificity minimizes cross-reactivity and background noise, providing clear and precise results in various applications:
High specificity: Target a single epitope, ensuring precise antigen detection
Low cross-reactivity: Minimize non-specific binding for cleaner results
Consistent performance: Derived from a single cell line for uniformity across experiments